Type 2 diabetes (T2D) typically starts with insulin resistance in peripheral tissues and proceeds with gradual loss of islet function due to the reduction in β-cell mass or dedifferentiation of β cells1,2. More than 30% of T2D patients eventually rely on exogenous insulin treatment. Cadaveric ...
Treating type 2 (non-insulin-dependent) diabetesGérard Slama
Empagliflozin is a new inhibitor of sodiumglucose cotransporters type 2 (SGLT2) for the treatment of type 2 diabetes mellitus (T2DM). Its specific action inhibits glucose reabsorption in renal tubules and thus promotes glucosuria. This effect results in a reduction in fasting and postprandial glyca...
Insulin analogues in type 1 diabetes mellitus: getting better all the time. Nat. Rev. Endocrinol. 13, 385–399 (2017). Article CAS PubMed Google Scholar Wu, K. K. & Huan, Y. Streptozotocin‐induced diabetic models in mice and rats. Curr. Protoc. Pharmacol. 40, 5.47.1–5.47.14 (...
被引量: 2发表: 2017年 International Journal of Current Medical and Pharmaceutical Research INSULIN REGIMEN FOR THE TREATMENT OF DIABETES MELITUS Diabetes mellitus type 1 is a form of diabetes in which not enough insulin is produced. The lack of insulin results in high blood sugar levels. The cl...
Diamant M, Heine RJ. Thiazolidinediones in type 2 diabetes mellitus: current clinical evidence. Drugs. 2003;63(13):1373–405. ArticleCASPubMedGoogle Scholar Tan M, et al. Effects of pioglitazone and glimepiride on glycemic control and insulin sensitivity in Mexican patients with type 2 diabetes ...
Type 2 diabetes mellitus (T2DM) is a globally prevalent metabolic disorder, and cardiovascular disease (CVD) is a significant cause of mortality and morbidity in diabetic individuals. In addition to hyperglycemia, lipid abnormalities associated with T2DM
Elderly patients with non-insulin-dependent (type 2) diabetes mellitus (NIDDM) form one of the largest sectors of the diabetic population. Emerging evidence indicates that hyperglycaemia is associated not just with an increased risk of m... DL Niskanen - 《Drugs & Aging》 被引量: 16发表: 199...
Patients with both hepatitis C and type 2 diabetes can develop fibrosis, steatosis, hepatocellular carcinoma, and resistance to antiviral treatment. Both insulin resistance (IR) and type 2 diabetes mellitus (T2DM) are more prevalent in patients with chronic hepatitis C virus (HCV) infection co...
INSULINNON-insulin-dependent diabetesInsulin therapy has proven benefits in Type 2 diabetes patients when combination therapy has failed. However, there is som... M Korytkowski - 《International Journal of Obesity》 被引量: 705发表: 0年 Do Non-Insulin-dependent Diabetes Mellitus and Cardiovascular...